source
- STAT+: Argenx to buy Forte Biosciences for $2.2BArgenx plans to buy Forte Biosciences for $2.2 billion, expanding its pipeline of drugs that could treat multiple autoimmune diseases.
- STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a “profound shock” last year, according to a new report from UNAIDS.